-LCB-_-LRB-
Induction_NN
of_IN
apoptosis_NN
in_IN
lymphocytes_NNS
by_IN
glucocorticoids_NNS
:_:
between_IN
physiology_NN
and_CC
pharmacology_NN
-RCB-_-RRB-

Glucocorticoids_NNS
are_VBP
physiological_JJ
molecules_NNS
that_WDT
are_VBP
also_RB
extensively_RB
used_VBN
in_IN
clinics_NNS
as_IN
anti-inflammatory_JJ
,_,
immunosuppressive_JJ
or_CC
anti-tumoral_JJ
agents_NNS
._.

Glucocorticoids_NNS
can_MD
induce_VB
apoptosis_NN
on_IN
normal_JJ
lymphoid_JJ
cells_NNS
and_CC
play_VB
a_DT
key_JJ
role_NN
in_IN
the_DT
physiology_NN
of_IN
thymic_JJ
selection_NN
._.

In_IN
clinics_NNS
these_DT
molecules_NNS
are_VBP
also_RB
used_VBN
for_IN
their_PRP$
potencies_NNS
in_IN
inducing_VBG
apoptosis_NN
of_IN
malignant_JJ
lymphoid_JJ
cells_NNS
._.

Glucocorticoids_NNS
are_VBP
mediating_VBG
their_PRP$
effects_NNS
after_IN
binding_NN
to_TO
an_DT
intracellular_JJ
receptor_NN
belonging_VBG
to_TO
the_DT
steroid_NN
receptor_NN
superfamily_NN
:_:
the_DT
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
._.

Once_IN
activated_VBN
,_,
the_DT
GR_NN
,_,
can_MD
mediate_VB
his_PRP$
effects_NNS
through_IN
direct_JJ
binding_NN
on_IN
the_DT
DNA_NN
or_CC
via_IN
protein\/protein_NN
interactions_NNS
with_IN
transcription_NN
factors_NNS
._.

Depending_VBG
on_IN
the_DT
type_NN
of_IN
lymphocytes_NNS
,_,
the_DT
mechanism_NN
of_IN
apoptosis_NN
induced_VBN
by_IN
glucocorticoids_NNS
fall_VBP
roughly_RB
in_IN
two_CD
categories_NNS
:_:
induction_NN
of_IN
``_JJ
death_NN
genes_NNS
''_VBN
by_IN
the_DT
activated_VBN
GR_NN
-LRB-_-LRB-
I_NN
kappa_NN
B_NN
,_,
c-jun_NN
-RRB-_-RRB-
or_CC
repression_NN
of_IN
survival_NN
factors_NNS
-LRB-_-LRB-
AP-1_NN
,_,
c-Myc_NN
-RRB-_-RRB-
._.

In_IN
the_DT
case_NN
of_IN
thymic_JJ
selection_NN
the_DT
mechanism_NN
is_VBZ
more_RBR
subtle_JJ
depending_VBG
on_IN
the_DT
mutual_JJ
repression_NN
of_IN
Nur77_NN
and_CC
GR_NN
._.

